US$ 22.76
cartalax vs bpc 157 Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing Cartalax vs BPC-157 Canada: Comparing
Description
It has been studied in equine medicine and in limited human trials for cardiac repair post-myocardial infarction

Tissue regeneration An in vitro study found that treating lung fibroblasts from COPD patients with GHK-Cu helped restore their function

This combination may be studied for traumatic brain injury, stroke, and neurodegenerative diseases like ALS and Alzheimers

For many of our patients, the results speak for themselves, and the improvements in look, feel, and function far outweigh the fact that current insurance companies refuse to recognize these improvements

Surgical options range and are decompressive in nature
